Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. RIC Transplant Using Haplo Donors

    ... will evaluate the safety and efficacy of a reduced intensity allogeneic HSCT from partially HLA -mismatched first-degree relatives utilizing PBSC as the stem cell source. The primary objective of the study is to estimate the ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  2. Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

    ... Purpose:  Allogeneic transplant can sometimes be an effective treatment for leukemia. In ... infusion of their donor's bone marrow or blood stem cells . The high-dose chemotherapy drugs and radiation are given to ...

    Clinical Trial last updated 05/09/2016 - 3:01pm.

  3. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with ... occurring < 30 months from diagnosis, relapse after previous allogeneic hematopoietic stem cell transplant [allo-HSCT], relapse ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  4. Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

    ... of improvement (relapsed), previously treated with donor stem cell transplant . Biological therapies, such as cellular adoptive ... Analysis Correlative studies Biological: WT1-Sensitized Allogeneic T-Lymphocytes Given IV ...

    Clinical Trial last updated 04/29/2016 - 10:34am.

  5. Clinical Trials Report for December 2015

    ... Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies ... has a Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated ...

    Page last updated 11/30/2015 - 10:31am.

  6. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... of such translocations Prior bone marrow or stem cell transplantation Candidate for allogeneic bone marrow or stem cell transplant Have achieved CR/CRi ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  7. Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    ... Purpose:  Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for patients ... Stem cell transplant Drug: Azacitidine Other Names: Vidaza Ladakamycin ...

    Clinical Trial last updated 05/03/2016 - 11:15am.

  8. Intra-Osseous Co-Transplant of UCB and hMSC

    ... the patient's immune system from rejecting the donor's stem cells . The donated stem cells may replace the patient's immune cells ... or chloroma) Recipients of prior autologous or allogeneic transplant are eligible, as long as at least 3 months have passed ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  9. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... (such as renal transplant) are excluded Patients with allogeneic stem cell transplantation within the last 6 months and patients with active ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  10. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... and low dose total body irradiation in patients undergoing allogeneic stem cell transplantation. A study population of 80 subjects will be enrolled ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.